Computerized Decision Support for High Cholesterol
(FH-ALERT Trial)
Recruiting in Palo Alto (17 mi)
Age: Any Age
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Brigham and Women's Hospital
No Placebo Group
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to learn if a computer alert can aid clinicians in identifying patients with a genetic type of high cholesterol, called Familial Hypercholesterolemia. The main question it aims to answer is whether the computer alert increases recognition of this high cholesterol disorder.
Research Team
Eligibility Criteria
This trial is for clinicians who manage patients with high cholesterol. It aims to see if a computer alert helps in recognizing Familial Hypercholesterolemia, a genetic disorder causing high cholesterol.Inclusion Criteria
Seen in the BWH Endocrinology, Cardiovascular Medicine, and Primary Care Clinics
I am 18 years old or older.
Dutch Lipid Clinic Network score of at least 3 points
Exclusion Criteria
A Familial Hypercholesterolemia diagnosis already documented in the EHR medical history, visit history, or problem list
Treatment Details
Interventions
- Alert-based computerized decision support (Behavioural Intervention)
Trial OverviewThe intervention being tested is an alert-based computerized decision support system designed to assist clinicians in identifying Familial Hypercholesterolemia among patients.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: AlertExperimental Treatment1 Intervention
In the Alert phase of 18 months, an on-screen alert through the Electronic Health Record will notify the ambulatory care clinician of record that the patient has a "definite," "probable," or "possible" diagnosis of FH but has not been recognized as such.
Group II: Pre-AlertActive Control1 Intervention
In the Pre-Alert phase of 6 months, patients meeting enrollment criteria will be identified but the clinician will not be notified regarding the possible diagnosis of Familial Hypercholesterolemia.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brigham and Women's Hospital
Lead Sponsor
Trials
1,694
Recruited
14,790,000+
Dr. William Curry
Brigham and Women's Hospital
Chief Medical Officer
MD from Columbia University College of Physicians and Surgeons
Dr. Scott Schissel
Brigham and Women's Hospital
Chief Executive Officer since 2021
MD from Columbia University College of Physicians and Surgeons